Efficacy and mechanism of traditional Chinese medicine in relieving antibiotic-resistant bacterial diarrhea in children: study protocol for a randomized controlled trial

Author:

Bi Chao-ran,Jing Wei,Xie Xiao-fei,Liu Yan-jing

Abstract

Abstract Background Bacterial infection is an important cause of diarrhea in children, potentially leading to malnutrition, growth and development disorders, and even death. Antibiotic abuse and resistance are widespread problems worldwide, especially in China. We therefore designed a study to evaluate the clinical efficacy and mechanism of traditional Chinese medicine in alleviating the effects of antibiotic resistance in childhood bacterial diarrhea and enhancing the sensitivity of pathogenic bacteria to antibiotics. Methods This randomized, double-blind, placebo-controlled clinical trial has completed ChiCTR registration. The trial will randomly divide 120 children who meet the inclusion criteria into three groups: experimental group 1 (basic treatment + Gegen Qinlian decoction granules + Erbai drink placebo), experimental group 2 (basic treatment + Erbai drink granules + Gegen Qinlian decoction placebo), and control group (basic treatment + Gegen Qinlian decoction placebo + Erbai drink placebo). The main efficacy indicators will be antibiotic use rate and clinical cure rate, and the secondary efficacy indicators will be time to antibiotic intervention, effective rate, and course of treatment determined after 5 days. The following physical and chemical indicators will be measured: routine blood parameters, procalcitonin, C-reactive protein, electrocardiogram, liver and kidney function, electrolytes, routine urinalysis, routine stool analysis, and stool culture (including drug sensitivity). Discussion The results of this study may provide an objective clinical basis for the use of traditional Chinese medicine in managing antibiotic-resistant bacterial diarrhea in children, formulating relevant guidelines, and demonstrating the use of traditional Chinese medicine for reducing the use of antibiotics. Trial registration Chinese Clinical Trial Registry ChiCTR1900027915. Last refreshed on December 4, 2019.

Funder

the National Key Research and Development Project

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Medicine (miscellaneous)

Reference16 articles.

1. Wang X, Wang J, Sun H, Xia SL, Duan R, Lian JR, et al. Etiology of childhood infectious diarrhea in a developed region of China:compared to childhood diarrhea in a developing region and adult diarrhea in a developed region. PLoS One. 2015;10(11):e0142136. https://doi.org/10.1371/journal.pone.0142136.

2. Wang P, Kang Q, Zhang HM, Yu DS. Monitoring and analysis on pathogens and drug resistance of bacterial diarrhea in Lanzhou in 2013. Chinese J Health Lab Technol. 2017;27:570–1.

3. Wang CJ, Lei C, Liu JF, Wei XG, Liu N, He HL. Bacterial diarrhoea pathogens among children, Xi’an,2004-2016. Modern Prev Med. 2017;44:2877–80.

4. Yuan HY, Zhang MX, Ma RW. Analysis of distribution and resistance to antibiotics of pathogenic bacteria in chil- dren ′s diarrhea in Taiyuan area from 2002 to 2007. Chinese J Microecol. 2008;20:589–90 593.

5. Cui EB, Chen SM, Zhang CL, Wang Y, Jia TY, Bao CM, et al. Distribution of the community-acquired bacterial diarrheal pathogens and drug resistance in 16 provinces or cities in China during 2009-2013. Infect Dis Inform. 2014;27:143–7.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3